The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago ...
GlaxoSmithKline Pharmaceuticals shares surged 20% to ₹2,421.30 after a strong Q3FY25 performance, reporting a 400% rise in ...
Shares of GlaxoSmithKline Pharmaceuticals Ltd ended at ₹2,608, up by ₹275.75, or 11.82%, on the BSE. Brokerage firms, ...
Glaxosmithkline Pharmaceuticals Ltd, Godfrey Phillips India Ltd, Prakash Industries Ltd and Kirloskar Brothers Ltd are among the other gainers in the BSE's 'A' group today, 17 February 2025.
GSK Pharma delivered a better-than-expected performance in Q3, largely driven by robust volume growth in the general medicine ...
GSK Pharma had reported a consolidated net profit of Rs 230 crore for Q3 FY25. This marks a significant surge of nearly 400 ...
Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...
A late-session recovery helped the 30-share BSE Sensex rise 57.65 points (0.08%) to close at 75,996.86. Earlier in the ...
GlaxoSmithKline Pharmaceuticals shares surged 20% to ₹2,421.30 after a strong Q3FY25 performance, reporting a 400% rise in ...